Abstract:Accurate in silico prediction of protein-ligand binding affinities has been a primary objective of structure-based drug design for decades due to the putative value it would bring to the drug discovery process. However, computational methods have historically failed to deliver value in real-world drug discovery applications due to a variety of scientific, technical, and practical challenges. Recently, a family of approaches commonly referred to as relative binding free energy (RBFE) calculations, which rely on physics-based molecular simulations and statistical mechanics, have shown promise in reliably generating accurate predictions in the context of drug discovery projects. This advance arises from accumulating developments in the underlying scientific methods (decades of research on force fields and sampling algorithms) coupled with vast increases in computational resources (graphics processing units and cloud infrastructures). Mounting evidence from retrospective validation studies, blind challenge predictions, and prospective applications suggests that RBFE simulations can now predict the affinity differences for congeneric ligands with sufficient accuracy and throughput to deliver considerable value in hit-to-lead and lead optimization efforts. Here, we present an overview of current RBFE implementations, highlighting recent advances and remaining challenges, along with examples that emphasize practical considerations for obtaining reliable RBFE results. We focus specifically on relative binding free energies because the calculations are less computationally intensive than absolute binding free energy (ABFE) calculations and map directly onto the hit-to-lead and lead optimization processes, where the prediction of relative binding energies between a reference molecule and new ideas (virtual molecules) can be used to prioritize molecules for synthesis. We describe the critical aspects of running RBFE calculations, from both theoretical and applied perspectives, using a combination of retrospective literature examples and prospective studies from drug discovery projects. This work is intended to provide a contemporary overview of the scientific, technical, and practical issues associated with running relative binding free energy simulations, with a focus on real-world drug discovery applications. We offer guidelines for improving the accuracy of RBFE simulations, especially for challenging cases, and emphasize unresolved issues that could be improved by further research in the field.

Large scale relative protein ligand binding affinities using non-equilibrium alchemy

On achieving high accuracy and reliability in the calculation of relative protein–ligand binding affinities

Validation of the Alchemical Transfer Method for the Estimation of Relative Binding Affinities of Molecular Series

Alchemical Binding Free Energy Calculations in AMBER20: Advances and Best Practices for Drug Discovery

Leveraging nonstructural data to predict structures and affinities of protein-ligand complexes

Relative Binding Free Energy Calculations for Ligands with Diverse Scaffolds with the Alchemical Transfer Method

Biomolecular conformational changes and ligand binding: from kinetics to thermodynamics.

Performance and Analysis of the Alchemical Transfer Method for Binding Free Energy Predictions of Diverse Ligands

Equilibrium and Non-equilibrium Ensemble Methods for Accurate, Precise and Reproducible Absolute Binding Free Energy Calculations

Identifying ligand binding sites and poses using GPU-accelerated Hamiltonian replica exchange molecular dynamics

Automated relative binding free energy calculations from SMILES to ΔΔG

Binding Affinity Prediction with 3D Machine Learning: Training Data and Challenging External Testing

Structure Determination of Challenging Protein-Peptide Complexes Combining NMR Chemical Shift Data and Molecular Dynamics Simulations

Concurrent and Adaptive Extreme Scale Binding Free Energy Calculations

Modeling Local Structural Rearrangements Using FEP/REST: Application to Relative Binding Affinity Predictions of CDK2 Inhibitors

A Method for Treating Significant Conformational Changes in Alchemical Free Energy Simulations of Protein-Ligand Binding

A high quality, industrial data set for binding affinity prediction: performance comparison in different early drug discovery scenarios

Binding Selectivity Analysis from Alchemical Receptor Hopping and Swapping Free Energy Calculations

Can molecular dynamics simulations improve predictions of protein-ligand binding affinity with machine learning?

Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations

Predicting binding events in very flexible, allosteric, multi-domain proteins